← all myths

Myth

"MDMA after four weeks is automatically safe."

review pending

Content is undergoing medical and legal review. Changes possible.

What's behind it

The '4-week rule' comes from the harm reduction tradition and is well intentioned — but it does not replace individual risk profiling. It is often understood as a guarantee, which it is not.

What's actually true

  • The 4-week rule reduces tolerance and neurotoxic risk — but it is only a rule of thumb, not a biological boundary.
  • Individual factors such as dose, setting, genetics (CYP2D6 polymorphisms), concurrent medication and physical condition matter more than the time interval.
  • Fatal MDMA complications have been documented even with the 4-week break observed — usually through hyponatremia, hyperthermia or serotonin syndrome.

What follows

4 weeks is a lower limit, not a safety guarantee. Long breaks (months) reduce risks cumulatively. The dose itself (≤ 100–125 mg per session, no redosing) matters at least as much as the interval.

The original recommendation of “at least a 4-week break” comes from harm reduction activists like Pillreports and Erowid and is based on the idea that the serotonin system recovers during this time.

The scientific evidence:

  • Animal studies show serotonin system recovery over weeks to months
  • Human data is thin — mostly self-reports and observational studies
  • Neurotoxicity is dose-dependent and not simply “recovered after time”

More important than the rigid rule are:

  • Maximum dose per session (≤ 1.5 mg/kg body weight is a conservative rule of thumb)
  • No redosing
  • Hydration with electrolytes (see hyponatremia scenario)
  • No SSRI/SNRI/MAO inhibitor combination
  • Use drug checking — cut or adulterated “MDMA” is common

The 4-week rule is a rule of thumb — not a promise.

Sources

  • Liechti et al., Pharmakokinetik von MDMA
  • drugcom MDMA-FAQ
  • TripSit MDMA Factsheet (Critical Notes)